Home › Research › Lewy body dementia
The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients
Jesús Silva‐Rodríguez, Miguel Ángel Labrador‐Espinosa, Linda Zhang, Sandra Castro‐Labrador, Francisco Javier López‐González, Alexis Moscoso, Pascual Sánchez‐Juan, Michael Schöll et al.. Brain, 2025-01-31
Topic: Brain proteins, microglia and lab models
Plain-language summary
Based on positive/negative results on the different biomarkers, subjects were classified as 'AD-LB-' (n = 304), 'AD+LB-' (n = 335), 'AD+LB+' (n = 158) and 'AD-LB+' (n = 68). We analysed group differences in regional FDG-PET patterns, demographics, APOE4 genotype, baseline and longitudinal domain-specific cognitive profiles (memory versus executive function/visuospatial performance), and risk for developing hallucinations. In FDG-PET, AD+LB+ showed more severe hypometabolism compared to AD+LB-, but both groups were characterized by largely identical patterns of temporo-parietal hypometabolism. APOE4 positivity was similar between AD+LB+ and AD+LB- (72% versus 75%, P = 0.28) but lower in AD-LB+ (28%, P < 0.001). On a group level, AD+LB+, AD+LB- and AD-LB+ showed similar risks of developing hallucinations, but patients with LB-like posterior-occipital hypometabolism had a significantly higher risk compared to those showing an AD-typical temporo-parietal pattern (hazard ratio = 2.58, P = 0.004). In conclusion, LB co-pathology in AD was associated with more severe hypometabolism and faster cognitive decline, but did not affect the regional hypometabolic pattern or cognitive profile. These findings indicate that the presence of LB pathology may have different consequences for the clinical phenotype depending on AD co-morbidity, which may have critical implications for accurate diagnosis and prognosis of patients presenting with amnestic syndromes.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 661 participants. Lewy body co-pathology in Alzheimer's disease was associated with more severe hypometabolism and faster cognitive decline, but did not affect the regional hypometabolic pattern or cognitive profile. These findings indicate the presence of Lewy body pathology may have different consequences depending on Alzheimer's disease co-morbidity, with implications for accurate diagnosis.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Silva‐Rodríguez, J., Labrador‐Espinosa, M. Á., Zhang, L., Castro‐Labrador, S., López‐González, F. J., Moscoso, A., et al. (2025). The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients. Brain. https://doi.org/10.1093/brain/awaf037
Vancouver
Silva‐Rodríguez J, Labrador‐Espinosa MÁ, Zhang L, Castro‐Labrador S, López‐González FJ, Moscoso A, et al. The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients. Brain. 2025. doi:10.1093/brain/awaf037. PMID: 39888600.
BibTeX
@article{silvarodriguez2025-39888600,
author = {Silva‐Rodríguez, Jesús and Labrador‐Espinosa, Miguel Ángel and Zhang, Linda and Castro‐Labrador, Sandra and López‐González, Francisco Javier and Moscoso, Alexis and Sánchez‐Juan, Pascual and Schöll, Michael and others},
title = {{The effect of Lewy body (co-)pathology on the clinical and imaging phenotype of amnestic patients}},
journal = {Brain},
year = {2025},
doi = {10.1093/brain/awaf037},
pmid = {39888600},
url = {https://doi.org/10.1093/brain/awaf037}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Based on positive/negative results on the different biomarkers, subjects were classified as 'AD-LB-' (n = 304), 'AD+LB-' (n = 335), 'AD+LB+' (n = 158) and 'AD-LB+' (n = 68).
- We analysed group differences in regional FDG-PET patterns, demographics, APOE4 genotype, baseline and longitudinal domain-specific cognitive profiles (memory versus executive function/visuospatial performance), and risk for developing hallucinations.
- In FDG-PET, AD+LB+ showed more severe hypometabolism compared to AD+LB-, but both groups were characterized by largely identical patterns of temporo-parietal hypometabolism.
- APOE4 positivity was similar between AD+LB+ and AD+LB- (72% versus 75%, P = 0.28) but lower in AD-LB+ (28%, P < 0.001).
- On a group level, AD+LB+, AD+LB- and AD-LB+ showed similar risks of developing hallucinations, but patients with LB-like posterior-occipital hypometabolism had a significantly higher risk compared to those showing an AD-typical temporo-parietal pattern (hazard ratio = 2.58, P = 0.004).
Why it matters
Lewy body co-pathology in Alzheimer's disease was associated with more severe hypometabolism and faster cognitive decline, but did not affect the regional hypometabolic pattern or cognitive profile. These findings indicate the presence of Lewy body pathology may have different consequences depending on Alzheimer's disease co-morbidity, with implications for accurate diagnosis.
Study details
- Study designlongitudinal study
- Participants661
- Evidence strengthModerate
How this study scored 65/100
Published in a leading specialty journal, and it is a longitudinal study following the same people over time. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Brain) |
| Journal's citation record | 4 / 4 | Brain: journal h-index 503 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 661 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 15 times (OpenAlex, 2026-10-10) |
| Citations per year | 2 / 5 | 5.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 4 / 6 | Cited 9.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 2 other studies in this library |
| Still being cited | 2 / 4 | Cited 15 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michel J. Grothe: h-index 56 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University College London: institution h-index 2,029 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 8 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 39888600) |
| Free to read | 2 / 2 | Free to read |
| Total | 65 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 20.
Later studies that cite this one
2 studies in the alzhub library list this one in their references.
Related studies in Lewy body dementia from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.